VIR BIOTECHNOLOGY
Live / Allowed — Notice of allowance issued (as of 17 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Jul 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98661988
- Mark type
- Design + words
- Filed
- 23 Jul 2024
- Published for opposition
- 23 Dec 2025
- Attorney of record
- Tamar Niv Bessinger
Goods and services
- Class 005 — Pharmaceuticals: Antiviral pharmaceuticals; antiviral pharmaceuticals for use in the treatment of infectious diseases and disorders and in the field of oncology
Owner
- Vir Biotechnology, Inc., San Francisco, CA, US
- Vir Biotechnology, Inc., San Francisco, CA, US
Prosecution history
- 17 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Dec 2025 — PUBLISHED FOR OPPOSITION
- 17 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Nov 2025 — EXAMINER'S AMENDMENT ENTERED
- 30 Nov 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 30 Nov 2025 — EXAMINERS AMENDMENT E-MAILED
- 30 Nov 2025 — EXAMINERS AMENDMENT -WRITTEN
- 02 Aug 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 02 Aug 2025 — FINAL REFUSAL E-MAILED
- 02 Aug 2025 — FINAL REFUSAL WRITTEN
- 21 Jul 2025 — DIVISIONAL PROCESSING COMPLETE
- 05 May 2025 — DIVISIONAL REQUEST RECEIVED
- 16 Jul 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL